Catalogues of EQ-5D-3L Health-Related Quality of Life Scores for 199 Chronic Conditions and Health Risks for Use in the UK and the USA.

Michael Falk Hvidberg Mónica Hernández Alava

Published in: PharmacoEconomics (2023)

This study provides comprehensive catalogues of UK/US EQ-5D-3L HRQoL utilities. Results are relevant in cost-effectiveness analysis, for NICE submissions, and for comparing and identifying facets of disease burden.

Keyphrases

cross sectional
risk factors
drug induced